Live tape
Top 8, mentions 7d7,505META2,263 mentions▲ +0.06GOOGL1,504 mentions▲ +0.02NVDA797 mentions▲ +0.09MUSE665 mentions▲ +0.07MSFT602 mentions▲ +0.05SPY567 mentions▲ +0.05QQQ557 mentions▲ +0.08TSLA550 mentions▲ +0.06

Equity · Communication Services

GENI

Genius Sports Limited · NYSE

$6 −1.32% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 23, 2026
Price · Chart
Our own end-of-day closes 60 sessions
$9 $5 30 Jun 23 Sep

The line runs $6.06 on 30 June through $6 on 23 September, on a scale from $5 to $9. Days the market did not trade hold the previous close, flat.

The chart above plots the price of GENI over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 60 sessions over that window: $6.06 on 30 June 2026 through $6 on 23 September 2026.

52-week range $3.93 – $13.43
Avg volume 539.2K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · as of Sep 23, 2026

Filings 3 sets

GENI reported financials

SEC EDGAR XBRL

GENI reported revenue of $669.5M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$111.6M.

Figure Reported Period
Revenue $669.5M 31 Dec 2025 fiscal year
Net income −$111.6M 31 Dec 2025 fiscal year
Diluted EPS −$0.44 31 Dec 2025 fiscal year
Total assets $1.1B 31 Dec 2025 at period end
Total equity $724.5M 31 Dec 2025 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Dec 2025

GENI institutional holders

SEC Form 13F

13 of the 45 institutional funds we track reported a GENI position for the quarter ended 30 Jun 2026 — a combined $160.2M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Glenview Capital Management Added +57.6% shares 13,495,287 $81.8M
Point72 Asset Management Held (±25%) +14.0% shares 3,979,980 $24.1M
ARK Investment Management Held (±25%) −8.0% shares 3,065,770 $18.6M
Man Group Added +148.5% shares 1,413,550 $8.6M
Balyasny Asset Management Trimmed −43.8% shares 1,089,209 $6.6M
Marshall Wace Trimmed −50.0% shares 1,018,036 $6.2M
AQR Capital Management Added +74.5% shares 956,980 $5.8M
Citadel Advisors Trimmed −79.9% shares 555,944 $3.4M
Millennium Management Added +89.0% shares 459,137 $2.8M
Renaissance Technologies Trimmed −91.1% shares 195,600 $1.2M

Showing the 10 largest of 13 reported positions. The figures above count all of them.

Source: SEC EDGAR 13F filings

GENI fails-to-deliver

SEC CNS data

On 27 Aug 2026, 3,363 shares of GENI failed to deliver (about $26K) — the latest of 4 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
27 Aug 2026 3,363 $26K 0.034%
26 Aug 2026 220,794 $1.8M 2.208%
25 Aug 2026 14,400 $115K 0.144%
24 Aug 2026 2,475 $20K 0.025%

Source: SEC fails-to-deliver (CNS) data